financetom
Market
financetom
/
Market
/
Lupin launches mental disorder treatment drug in the United States
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lupin launches mental disorder treatment drug in the United States
Feb 21, 2023 11:53 AM

Global pharmaceutical major Lupin Ltd. on Tuesday said that it has launched Lurasidone Hydrochloride Tablets, a generic equivalent of the Latuda Tablets, in the United States.

Share Market Live

NSE

Latuda Tablets are used in the treatment of mental disorders like bipolar disorder and schizophrenia in children and adults.

Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, are a generic equivalent of Latuda Tablets of Massachusetts-based Sunovion Pharmaceuticals, Inc.

The drug had an estimated annual sale of $4.2 billion in the US as of December 2022, according to IQVIA data.

The drug maker also recently received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) following an inspection at its new injectable facility located in Nagpur, Maharashtra. The inspection was conducted between October 17 to October 29, 2022.

The company’s share prices have dropped over 11 percent in the past month. Shares declined sharply after Lupin reported a 72 percent decline year-on-year in its consolidated net profit for the December quarter.

Analysts and brokerages expected further weakness in the stock, especially for the company’s March quarter results with experts counting on the launch of the Spiriva generic drug to boost the company’s revenue growth and margin recovery.

Headquartered in Mumbai, Lupin operates 15 manufacturing sites along with 7 research centres. The company employs more than 20,000 individuals across the globe.

Shares of Lupin Ltd. ended 0.63 percent higher at Rs 671.30 on Tuesday.

(Edited by : Rukmani Krishna)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Dow briefly hits record high on UnitedHealth boost; Trump-Putin meet in focus
US STOCKS-Dow briefly hits record high on UnitedHealth boost; Trump-Putin meet in focus
Aug 15, 2025
* Indexes: Dow up 0.20%, S&P 500 down 0.28%, Nasdaq off 0.47% * UnitedHealth ( UNH ) surges after Berkshire Hathaway ( BRK/A ) investment * Applied Materials ( AMAT ) drops on weak China demand forecast * Investors monitor Trump-Putin summit at Alaska (Updates with early afternoon prices) By Johann M Cherian and Sanchayaita Roy Aug 15 (Reuters) -...
Sector Update: Health Care
Sector Update: Health Care
Aug 15, 2025
12:57 PM EDT, 08/15/2025 (MT Newswires) -- Health care stocks gained Friday afternoon, with the NYSE Health Care Index rising 1.7% and the Health Care Select Sector SPDR Fund (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 1.1%. In corporate news, UnitedHealth Group ( UNH ) jumped past 13% after Berkshire Hathaway (BRK.A, BRK.B) said in a filing that...
US Equity Indexes Mixed Ahead of Trump-Putin's Alaska Summit; UnitedHealth Helps Lift Dow
US Equity Indexes Mixed Ahead of Trump-Putin's Alaska Summit; UnitedHealth Helps Lift Dow
Aug 15, 2025
12:26 PM EDT, 08/15/2025 (MT Newswires) -- US equity indexes were mixed in midday trading prior to the Alaska summit on Friday, while investors weighed retail sales and the University of Michigan's survey data for inflation expectations. The Nasdaq Composite fell 0.5% to 21,607.3, and the S&P 500 slid 0.3% to 6,450.7, while the Dow Jones Industrial Average rose 0.2%...
Wall Street trains sights on Jackson Hole Fed gathering
Wall Street trains sights on Jackson Hole Fed gathering
Aug 15, 2025
(Reuters) -Investors will next week train their sights on Jackson Hole, Wyoming, where Federal Reserve policymakers gather for their annual policy symposium, in a search for clues on the path of interest rate cuts that could boost stocks to more record highs.  This year's gathering follows a week in which consumer and wholesale price data appeared to send mixed signals...
Copyright 2023-2026 - www.financetom.com All Rights Reserved